TCL Archive Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced November 5, 2010
TCL Archive Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster” May 6, 2011
TCL Archive In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm January 31, 1986
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer June 28, 2002
